Total Funding
60
56
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
32 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
34798
WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .
Jill Amstutz: VP Strategic MarketingPast Role: Neuravi, Vice President of Global Marketing- Paul Frehill: Senior Engineering ManagerPast Role: Kite Medical, CTO
About the Company
WhiteSwell is a science-driven company dedicated to improving the treatment of acute decompensated heart failure (ADHF), which is a leading cause of hospitalization and emergency room visits. The WhiteSwell team investigated the therapeutic potential of the lymphatic system in order to address this significant clinical need. Its solution is unique
in that it allows fluid removal from both the interstitial and intravascular compartments.
